Skip to content

Advertisement

  • Case report
  • Open Access
  • Open Peer Review

Unilateral renal artery stenosis presented with hyponatremic-hypertensive syndrome – case report and literature review

  • 1, 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7 and
  • 1Email author
BMC Nephrology201920:64

https://doi.org/10.1186/s12882-019-1246-9

  • Received: 19 December 2018
  • Accepted: 1 February 2019
  • Published:
Open Peer Review reports

Abstract

Background

Renal artery stenosis is one of the secondary causes of pediatric hypertension. Cases with critical unilateral renal artery stenosis manifesting with the hyponatremic hypertensive syndrome are rare and a comprehensive description of this disorder in the pediatric population is lacking in the literature.

Case presentation

We describe a 4-year-old boy who presented with severe hypertension, profound hyponatremia, hypokalemia, nephrotic range proteinuria, and polyuria. Distinctly, the diagnosis of hyponatremic hypertensive syndrome secondary to unilateral renal artery stenosis was confirmed in light of laboratory and radiographic findings of severe natriuresis, elevated renin, and unilateral small kidney. Two weeks following nephrectomy, there was resolution of hyponatremia, hypokalemia, nephrotic range proteinuria and hypertension.

Conclusions

Findings of hyponatremia, hypokalemia, hypertension, polyuria, and unilateral renal hypoplasia can be attributed to a unifying pathology of unilateral renal artery stenosis.

Keywords

  • Hyponatremic-hypertensive syndrome
  • Renal artery stenosis

Background

Hypertension in children necessitates prompt work-up and diagnosis in order to uncover and appropriately treat secondary causes, such as coarctation of the aorta, renal parenchymal diseases, renal artery stenosis, and endocrine disorders. Concurrent hyponatremia in hypertension is most commonly caused by renin-secreting tumors, renal ischemia, and renal artery stenosis after exclusion of medication-induced hypertension [1]. The central pathomechanism that underlies hyponatremic hypertension syndrome (HHS) is the stimulation and activation of the renin-angiotensin-aldosterone (RAA) axis which consequently trigger hypertension through vasoconstriction as well as fluid and salt retention. In cases of unilateral renal artery stenosis, angiotensin II induces pressure natriuresis of the non-stenotic kidney and hence produces the unique finding of hyponatremia in conjunction with hypertension.

Hyponatremic hypertensive syndrome, a disorder of severe hypertension and hyponatremia, could result from any causes of high renin conditions. The most common etiology in children is unilateral renal artery stenosis. It could present with of conscious disturbance or seizure, polydipsia and polyuria, with the characteristics of extreme hypertension, hyponatremia, hypokalemia, and proteinuria. Due to its insidious course and potential fatality, it warrants careful investigation by an astute physician [2]. Without appropriate treatment, hypertensive encephalopathy, retinopathy, cardiomyopathy, and nephropathy can develop.

Herein, we present a 4-year-old boy with HHS, caused by unilateral renal artery stenosis, featured by hypertension, hyponatremia, polyuria, and polydipsia. After nephrectomy, he achieved full clinical recovery without sequelae.

Case presentation

A 4-year-old boy, who had no systemic or inherited disease, presented with a 3-week history of intermittent vomiting without diarrhea or abdominal pain. In the past year, he experienced polydipsia and polyuria. Physical examination revealed body weight 17.5 kg (50th percentile), body height 100 cm (15~50th percentile), blood pressure 230/120 mmHg, heart rate 138 /min, and decreased skin turgor. There was no focal neurological deficit, blood pressure discrepancy between upper and lower extremities, palpable mass, nor any appreciation of an abdominal thrill. Laboratory studies revealed serum Na+ 124 mmol/L, K+ 2.4 mmol/L, Cl 87 mmol/L, Ca2+ 8.5 mg/dL, HCO3 34.5 mEq/L, creatinine 0.41 mg/dL, albumin 3.4 g/dL, IgG 247 mg/dL, and osmolality 290 mOsm/KgH2O. Urine analysis was significant for creatinine 11.2 mg/dL, Na+ 24 mEq/L, K+ 18 mEq/L, Cl 24 mEq/L, osmolality 232 mOsm/KgH2O, RBC 168/μL, FENa 6%, and nephrotic-range proteinuria (55 mg/m2/hour). Survey for possible glomerulonephritis demonstrated the absence of anti-streptolysin O, p-ANCA, c-ANCA, ANA, and normal immunoglobulin A, C3, and C4 levels. In addition, work-up for secondary hypertension included: free T4 1.51 (normal range 0.8–2.0 ng/dL), TSH 5.7 (normal range 0.25–5.00 μIU/mL), cortisol 40.18 (normal range 4.3–25 μg/dL), ACTH 9.32 (normal range < 46 pg/mL), renin 1745 (normal range 2–15 ng/L), aldosterone 92.6 (normal range 4–25 ng/dL), and urine vanillylmandelic acid 3.8 (normal range 1.9–9.9 g/day). Renal ultrasonography revealed hyperechoic right kidney (7.6 cm in length) and small left kidney (5.3 cm in length). Due to the presence of hyperreninemic hypertension, natriuretic-hyponatremia, hypokalemia, and nephrotic range proteinuria, HHS was highly suspected. Computed tomography angiography confirmed high-grade renal artery stenosis with hypoplasia of the left kidney (Fig. 1).
Fig. 1
Fig. 1

Computed tomographic angiography with maximum intensity projection. The axial view demonstrated the small caliber of the left renal artery (black arrow) with the compensatory change of the contralateral renal artery (white arrow)

In terms of management for this case, we began with volume repletion by normal saline administration. Subsequently, his blood pressure declined from 210/120 mmHg to 180/90 mmHg. Intravenous calcium channel blocker was used to treat his hypertensive emergency, while oral captopril was prescribed for RAA axis blockage after diagnosis of unilateral renal artery stenosis. The systolic blood pressure gradually declined to 150~160 mmHg on the 3rd day. Potassium supplement was infused for his profound hypokalemia and generalized muscle weakness. Due to the severity of left renal artery stenosis, he was not a candidate for angiographic intervention, and decision was made to proceed with left nephrectomy. Overall, electrolyte abnormalities such as hyponatremia and hypokalemia were corrected within 1 week after admission, and resolution of polyuria, polydipsia, proteinuria, and hypertension were achieved 2 weeks after nephrectomy (Additional file 1: Table S1).

Discussion and conclusions

This 4-year-old boy presented with severe hypertension and volume depletion. Comprehensive examinations excluded the possibility of coarctation of great vessels and renal parenchymal diseases and pointed towards an overactive renin-angiotensin-aldosterone axis. The presentation of natriuretic-hyponatremia, hypokalemia, polyuria, nephrotic range proteinuria, and hyperreninemic-hypertension was highly suggestive of HHS. Aside from HHS, primary neurologic diseases such as intracranial hemorrhage or malignancy may also cause hypertension and hyponatremia, secondary to the increase in intracranial pressure and inappropriate secretion of antidiuretic hormone. However, these diseases usually present with focal neurologic deficits and decreased urine output, which could be distinguished from the polyuria and volume depletion of HHS caused by the renal artery stenosis.

The main pathogenesis of HHS is renal ischemia, as shown in Fig. 2. Hypertension is induced by stimulation of unremitted renin secretion and subsequent angiotensin II-induced vasoconstriction and secondary hyperaldosteronism. Elevated circulating angiotensin II can cause glomerular hyperfiltration and subsequential pressure natriuresis of the non-stenotic kidney, which results in the clinical presentation of hyponatremia [3]. In addition, volume depletion contributes to the development of hyponatremia by stimulating the secretion of the anti-diuretic hormone. Sodium wasting and volume depletion further stimulates the renin excretion [4]. Hyperaldosteronism, secondary to hyperreninemia and volume depletion, lead to hypokalemia which is one of the leading complications of HHS. Glomerular hyperfiltration of contralateral healthy kidney, deriving from hyperreninemia-induced hypertension, could eventually result in tubulointerstitial injury from the effects of hypercalciuria and hyperuricosuria [5]. Proteinuria in cases of HHS, sometimes in nephrotic range, can result from the glomerular hyperfiltration, proteinuric effect of angiotensin II, and/or consequence of tubulointerstitial injury caused by prolonging hypercalciuria and hyperuricosuria [6].
Fig. 2
Fig. 2

Possible mechanism of hyponatremic-hypertensive syndrome

We conducted a careful search of literature and found a total of 15 reported pediatric cases, as shown in Table 1. The mean age at onset was 4.03 ± 3.38 years with male predominance (11/15). The combination of hypertension, polydipsia, and polyuria are the most common presentations (14/15), followed by hyponatremic seizure (7/15). The mean serum sodium, potassium, and bicarbonate levels were 123.4 ± 5.5 mEq/l, 2.9 ± 0.5 mEq/l, and 28.9 ± 3.5, respectively. Eight of the patients had proteinuria. Excluding the three patients whose renin and aldosterone data was unavailable, almost all patients had hyperreninemia (10/11) and hyperaldosteronism (12/12). The most common extra-renal involvements were neurological (8/15), cardiac (7/15), and retinal (5/15).
Table 1

Summary of Clinical Characteristics of Reported Pediatric Cases

Patient

[Ref]

Gender/ age

Presentations

BP (mmHg)

Renin (range)

Aldosterone

SNa (mEq/L)

SK (mEq/L)

SHCO3- (mEq/L)

Proteinuria

Organs involvement

Treatment

Outcome

1 [2]

F/ 2y9m

Polydipsia, polyuria

Presyncope

215/156

Low

Elevated

129

3

27

700 mg/day

CNSa

Kidney

IV β blocker,

oral β blocker, CCBb, ACEIc

dPTA

Recovery

2 [2]

M/ 2y3m

Polydipsia

142/92

NA

Elevated

122

3.9

25.9

3200 mg/day

Heart

Kidney

IV β blocker, oral β blocker, CCB, ACEI

PTA

Recovery

3 [2]

M/ 2y

Polydipsia, polyuria

Restlessness

220/150

Elevated

Elevated

125

3.2

27.2

5300 mg/day

Heart

Kidney

IV β blocker, oral β blocker, CCB, ACEI

PTA

Recovery

5 [9]

M/ 1y6m

Seizure, hemorrhagic and ischemic stroke

210/160

172 ng/ml/min (3~11)

91 ng/dl (4~16)

120

2.1

NAe

NA

CNS

Heart

Kidney

Nitroprusside, IV β blocker, oral CCB

Aorto-renal bypass

Hypertension

4 [14]

F/ 1y3m

Polyuria, polydipsia

190/120

24 ng/ml/hr. (1~4.5)

8 nmol/l (0.1~0.8)

122

2.4

29.5

1800 mg/day

Heart

Kidney

ACEI, β blocker, CCB, spironolactone

PTA

Recovery

6 [15]

M/ 7y

Polydipsia, polyuria

210/120

NA

NA

114

2.4

NA

NA

Retina

Kidney

CCB, α1 blocker Nephrectomy

Recovery

7 [16]

M/ 2y9m

Polydipsia, polyuria Seizure

160/120

80.44 ng/ml/hr. (0.2~2.8)

6861 pg/ml (10~160)

118

1.9

NA

NA

CNS

Kidney

CCB, desmopressin ACEI

Nephrectomy

Recovery

8 [16]

F/ 1y4m

Polyuria, polydipsia

140/90

NA

NA

131

2.6

NA

NA

Kidney

CCB

ACEI

Nephrectomy

Hypertension

9 [17]

M/ 9y

Polyuria, polydipsia Seizure

156/120

NA

NA

124

3.2

34

NA

CNS

Retina

Kidney

Nitroprusside ACEI, CCB

PTA with stenting

Hypertension

10 [18]

M/ 1y7m

Polyuria Polydipsia Seizure

248/150

137 ng/ml/min (3~11)

743 ng/dl (7~93)

128

3.2

24

NA

CNS

Heart

Kidney

Nitroprusside, ACEI

PTA with stent

Hypertension

11 [19]

M/ 5y

Seizure

236/132

21.06 ng/ml/hr. (1.3~3.9)

1172 ng/dl (1~16)

112

3.2

33.4

fUP/UCr 6.84

CNS

Kidney

β blocker, CCB, hydralazine

Proteinuria

Hypertension

12 [19]

M/ 8y

Polydipsia, polyuria Seizure

184/110

32.8 ng/ml/hr. (1.3~3.9)

1436 ng/dl (1~16)

127

3.1

27.2

UP/UCr 3.91

CNS

Retina

Kidney

β blocker, CCB, hydralazine

PTA

Recovery

13 [19]

M/ 12y

Polydipsia, polyuria Seizure

244/166

25.04 ng/ml/hr. (1.3~3.9)

1358 ng/dl (1~16)

126

3.2

32.2

UP/UCr 4.36

CNS

Retina

Kidney

β blocker, CCB, hydralazine

PTA with stenting

Hypertension

14 [20]

M/ 2y

Polydipsia, polyuria

NA

2537 ng/dl

31.6 ng/dl

124

2.8

NA

1230 mg/day

Heart

Kidney

Hydralazine

Angioplasty with patch

Recovery

15 [20]

F/ 2y

Polydipsia, polyuria

NA

76.5 ng/dl

48.1 ng/dl

128

2.7

NA

2400 mg/day

Heart

Retina

Kidney

CCB, β blockers, hydralazine

Angioplasty with patch

Recovery

Our case

M/ 4y

Polyuria, polydipsia

230/120

174.5 ng/dl

9.26 ng/dl

124

2.4

34.5

55 mg/m2/hr

Kidney

IV CCB,

Oral ACEI

Nephrectomy

Recovery

aCNS, central nervous system; bCCB, calcium channel blocker; cACEI, angiotensin-converting enzyme inhibitor; dPTA, percutaneous transluminal angioplasty; eNA, not available; furine protein-to-creatinine ratio (mg/dl/ mg/dl)

The mainstay of treatment for renal artery stenosis-associated HHS lies in the restoration of intravascular volume, prevention of acute insult of hypertensive crisis and correction of underlying renal arterial stenosis. Volume depletion needs to be corrected first to improve systemic blood flow and prevent further injury resulting from renal ischemia [7]. After volume repletion, the prompt decline of blood pressure could be achieved by intravenous calcium channel blocker, which has been suggested to be the first line drug for severe hypertension with acute kidney injury [8]. For cases with HHS, angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker should be introduced to mitigate the over-activation of the RAA system [9]. However, the use of diuretics is not recommended due to the potential deleterious effects of fluid and sodium wasting which could further activate the RAA system [10]. Lastly, correction of renal artery stenosis can be achieved surgically by percutaneous renal angioplasty, renal artery reconstruction, or nephrectomy. As shown in Table 1, all patients received anti-hypertensive agents as the first line therapy. Eleven and three cases underwent angioplasty and unilateral nephrectomy, respectively. It is important to note that HHS caused by renal artery stenosis does not always result in a favorable outcome, as five patients had residual hypertension despite aggressive treatment. Several causes of residual hypertension in cases with HHS have been proposed. A longitudinal pediatric study stated that over 40% of renal artery angioplasty would develop restenosis [11]. Also, chronic kidney disease caused by prolonging tissue hypoxia and consequence of proteinuria could lead to hypertension despite restoration of renal blood flow [12]. Finally, uncontrolled hypertension itself could cause irreversible remodeling of vascular endothelium, resulting in permanent hypertension [13].

In conclusion, HHS caused by unilateral renal artery stenosis is a potentially curable and reversible disease when promptly diagnosed and appropriate treatment is implemented. Hyperreninemic hypertension, natriuretic hyponatremia, nephrotic range proteinuria, and unilateral renal hypoplasia are clinical clues that aid in uncovering the diagnosis.

Abbreviation

HHS: 

Hyponatremic hypertension syndrome

Declarations

Acknowledgments

Not applicable.

Funding

None.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Authors’ contributions

JD, JL, HC, and MT acquired the data necessary for analysis. JD wrote the initial draft of the paper. JH, TW, SL, and MT contributed in data analysis and interpretation. TW, JL, and SL were involved in drafting and revising the manuscript. All authors approved the final version of the manuscript prior to submission. All authors agreed to be accountable for all aspects of the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent was obtained from the parents/guardians of the children.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Division of Nephrology, Department of Pediatrics, Chang Gung Memorial Hospital and Chang Gung University, No 5, Fu-Shing ST., Kwei-Shan, 33305 Taoyuan, Taiwan
(2)
Department of Pediatrics, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
(3)
Division of Nephrology, Department of Medicine, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
(4)
Division of Pediatric Surgery, Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Linkou, Taiwan
(5)
Department of Pediatrics, Fetal and Neonatal Institute, Division of Neonatology Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
(6)
Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
(7)
Division of Cardiology, Department of Pediatrics, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan

References

  1. Agarwal M, Lynn KL, Richards AM, Nicholls MG. Hyponatremic-hypertensive syndrome with renal ischemia: an underrecognized disorder. Hypertens (Dallas, Tex 1979). 1999;33:1020–4.View ArticleGoogle Scholar
  2. Kovalski Y, Cleper R, Krause I, Dekel B, Belenky A, Davidovits M. Hyponatremic hypertensive syndrome in pediatric patients: is it really so rare? Pediatr Nephrol. 2012;27:1037–40.View ArticleGoogle Scholar
  3. Ivy JR, Bailey MA. Pressure natriuresis and the renal control of arterial blood pressure. J Physiol. 2014;592:3955–67.View ArticleGoogle Scholar
  4. Zieg J. Pathophysiology of Hyponatremia in Children. Front Pediatr. 2017. https://doi.org/10.3389/fped.2017.00213.
  5. Sendromlu H-H, Çocuk AE, Yılmaz D, Kelimeler A. Hyponatremic-hypertensive syndrome Hyponatremic-hypertensive syndrome in an 18-month-old male child. J Clin Anal Med. 2015;6(suppl 6):883–5.Google Scholar
  6. Ogata H, Ishiyama N, Hamabe K, Tabata T, Mitsuhasi K, Miki T, et al. Renovascular Hypertension with Massive Proteinuria. Intern Med. 1996;35:569–73.Google Scholar
  7. van Tellingen V, Lilien MR, Bruinenberg JFM, de Vries WB. The Hyponatremic Hypertensive Syndrome in a Preterm Infant: A Case of Severe Hyponatremia with Neurological Sequels. Int J Nephrol. 2011;2011:1–4.View ArticleGoogle Scholar
  8. Aronow WS. Treatment of hypertensive emergencies. Ann Transl Med. 2017;5:S5.View ArticleGoogle Scholar
  9. Dixit MP, Hughes JD, Theodorou A, Dixit NM. Hyponatremic hypertensive syndrome (HHS) in an 18-month old-child presenting as malignant hypertension: a case report. BMC Nephrol. 2004;5:5.View ArticleGoogle Scholar
  10. Singh D, Akingbola O, Yosypiv I, El-Dahr S. Emergency Management of Hypertension in Children. Int J Nephrol. 2012. https://doi.org/10.1155/2012/420247.
  11. Zhu G, He F, Gu Y, Yu H, Chen B, Hu Z, et al. Angioplasty for pediatric renovascular hypertension: a 13-year experience. Diagnostic Interv Radiol. 2014;20:285–92.View ArticleGoogle Scholar
  12. Textor SC. “Renovascular hypertension: is there still a role for stent revascularization? ” Current opinion in nephrology and hypertension. Curr Opin Nephrol Hypertens. 2013;22:1.View ArticleGoogle Scholar
  13. Bleakley C, Hamilton PK, Pumb R, Harbinson M, Mcveigh GE. Endothelial function in hypertension: victim or culprit? J Clin Hypertens. 2015;17:651–4.View ArticleGoogle Scholar
  14. Seracini D, Pela I, Favilli S, Bini RM. Hyponatraemic-hypertensive syndrome in a 15-month-old child with renal artery stenosis. Pediatr Nephrol. 2006;21:1027–30.View ArticleGoogle Scholar
  15. Neeli S. Renal artery stenosis with hyponatremic hypertensive syndrome in a 7-year-old child. J Pediatr Urol. 2008;4:407–8.View ArticleGoogle Scholar
  16. D’Angelo P, Catania S, Zirilli G, Collini P, Tropia S, Perotti D, et al. Severe polyuria and polydipsia in hyponatremic-hypertensive syndrome associated with Wilms tumor. Pediatr Blood Cancer. 2010;55:566–9.View ArticleGoogle Scholar
  17. Pandey M, Sharma R, Kanwal SK, Chhapola V, Awasthy N, Mathur A, et al. Hyponatremic-hypertensive syndrome: think of unilateral renal artery stenosis. Indian J Pediatr. 2013;80:872–4.View ArticleGoogle Scholar
  18. Parikh P, Duhame D, Monahan L, Woroniecki R. Renal artery stenosis precipitates hyponatremic hypertensive syndrome and posterior reversible leukoencephalopathy. Front Pediatr. 2015. https://doi.org/10.3389/fped.2015.00040.
  19. Mukherjee D, Sinha R, Akhtar MS, Saha AS. Hyponatremic hypertensive syndrome - a retrospective cohort study. World J Nephrol. 2017;6:41.View ArticleGoogle Scholar
  20. Trivelli A, Ghiggeri GM, Canepa A, Oddone M, Bava G, Perfumo F. Hyponatremic-hypertensive syndrome with extensive and reversible renal defects. Pediatr Nephrol. 2005;20:102–4.View ArticleGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement